Pages that link to "Q28139662"

The following pages link to Three new familial hemiplegic migraine mutants affect P/Q-type Ca(2+) channel kinetics (Q28139662):

Displaying 50 items.

• A CACNA1F mutation identified in an X-linked retinal disorder shifts the voltage dependence of Cav1.4 channel activation. (Q24302179) (← links)
• Muscle channelopathies and critical points in functional and genetic studies (Q24532297) (← links)
• Familial hemiplegic migraine mutations increase Ca(2+) influx through single human CaV2.1 channels and decrease maximal CaV2.1 current density in neurons (Q24538702) (← links)
• Effects of familial hemiplegic migraine type 1 mutations on neuronal P/Q-type Ca2+ channel activity and inhibitory synaptic transmission (Q24556684) (← links)
• Impact of ESR1 Gene Polymorphisms on Migraine Susceptibility: A Meta-Analysis (Q26786189) (← links)
• G protein regulation of neuronal calcium channels: back to the future (Q26829909) (← links)
• A Single Amino Acid Deletion (ΔF1502) in the S6 Segment of CaV2.1 Domain III Associated with Congenital Ataxia Increases Channel Activity and Promotes Ca2+ Influx (Q28118912) (← links)
• Delayed cerebral edema and fatal coma after minor head trauma: role of the CACNA1A calcium channel subunit gene and relationship with familial hemiplegic migraine (Q28202137) (← links)
• Specific kinetic alterations of human CaV2.1 calcium channels produced by mutation S218L causing familial hemiplegic migraine and delayed cerebral edema and coma after minor head trauma (Q28237739) (← links)
• Gating deficiency in a familial hemiplegic migraine type 1 mutant P/Q-type calcium channel (Q28241997) (← links)
• The CACNA1F gene encodes an L-type calcium channel with unique biophysical properties and tissue distribution (Q28245875) (← links)
• CACNA1B mutation is linked to unique myoclonus-dystonia syndrome (Q28249383) (← links)
• Familial hemiplegic migraine type 1 mutations K1336E, W1684R, and V1696I alter Cav2.1 Ca2+ channel gating: evidence for beta-subunit isoform-specific effects (Q28284668) (← links)
• The impact of pharmacogenetics for migraine (Q31925619) (← links)
• Neurobiology of migraine. (Q33186891) (← links)
• Migraine: new molecular mechanisms (Q33220839) (← links)
• Familial hemiplegic migraine (Q33280531) (← links)
• Molecular endpoints of Ca2+/calmodulin- and voltage-dependent inactivation of Ca(v)1.3 channels (Q33530299) (← links)
• CaV2.1 channelopathies (Q33537218) (← links)
• A mutation in the first intracellular loop of CACNA1A prevents P/Q channel modulation by SNARE proteins and lowers exocytosis. (Q33667575) (← links)
• Calcium channels and synaptic transmission in familial hemiplegic migraine type 1 animal models. (Q33680269) (← links)
• Gain of function in FHM-1 Cav2.1 knock-in mice is related to the shape of the action potential (Q33995411) (← links)
• Molecular determinants of inactivation in voltage-gated Ca2+ channels (Q34061997) (← links)
• Molecular pharmacology of high voltage-activated calcium channels (Q34303106) (← links)
• The inherited episodic ataxias: how well do we understand the disease mechanisms? (Q34326582) (← links)
• Familial hemiplegic migraine: a ion channel disorder (Q34446556) (← links)
• Calcium channels and channelopathies of the central nervous system (Q34560191) (← links)
• The neuronal channelopathies (Q34649239) (← links)
• Genetics of migraine: possible links to neurophysiological abnormalities (Q34669318) (← links)
• Functional roles of cytoplasmic loops and pore lining transmembrane helices in the voltage-dependent inactivation of HVA calcium channels. (Q35157838) (← links)
• The genetics of migraine (Q35172431) (← links)
• Neurological disorders caused by inherited ion-channel mutations (Q35172474) (← links)
• A single amino acid mutation attenuates rundown of voltage-gated calcium channels (Q35215370) (← links)
• Targeting mechanisms of high voltage-activated Ca2+ channels (Q35682314) (← links)
• In vivo analysis of voltage-dependent calcium channels (Q35682326) (← links)
• The molecular genetics of migraine (Q35932365) (← links)
• Pathophysiological role of omega pore current in channelopathies (Q36022793) (← links)
• Migraine genetics: an update (Q36133899) (← links)
• Molecular basis of inherited calcium channelopathies: role of mutations in pore-forming subunits (Q36513343) (← links)
• Voltage-gated calcium channels and idiopathic generalized epilepsies. (Q36525559) (← links)
• Migraine: a complex genetic disorder (Q36825299) (← links)
• An autism-associated mutation in CaV1.3 channels has opposing effects on voltage- and Ca(2+)-dependent regulation (Q36964814) (← links)
• Molecular mechanisms of migraine? (Q36995199) (← links)
• Optimizing prophylactic treatment of migraine: Subtypes and patient matching (Q37052803) (← links)
• Two novel alleles of tottering with distinct Ca(v)2.1 calcium channel neuropathologies (Q37079538) (← links)
• Neuro-ophthalmologic manifestations of primary headache disorders (Q37146193) (← links)
• The E1015K variant in the synprint region of the CaV2.1 channel alters channel function and is associated with different migraine phenotypes (Q37333758) (← links)
• Screening of CACNA1A and ATP1A2 genes in hemiplegic migraine: clinical, genetic, and functional studies. (Q37398107) (← links)
• The S218L familial hemiplegic migraine mutation promotes deinhibition of Ca(v)2.1 calcium channels during direct G-protein regulation (Q37475732) (← links)
• Use of calcium channel blockers for glaucoma (Q37799002) (← links)